Download PDF
Deutsche Heilpraktiker-Zeitschrift 2014; 9(05): 38-43
DOI: 10.1055/s-0034-1395402
Praxis
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Das Powervitamin

Claudia Vollbracht
,
Rainer Suda
Subject Editor:
Further Information

Publication History

Publication Date:
31 October 2014 (online)

    Permissions and Reprints

Summary

Vitamin C kann hochdosiert nur als Infusion eingesetzt werden, die notwendigen Wirkspiegel lassen sich physiologisch nicht anders erreichen. Vitamin-C-Mangelzustände sind die Hauptindikation für die Hochdosistherapie, sie entstehen durch unterschiedliche Erkrankungen. Die Infusionsbehandlung ist relativ problemlos durchzuführen, vorausgesetzt das richtige Trägermedium wird verwendet, die richtige Verdünnung und Infusionsgeschwindigkeit werden beachtet.

Keywords

Hochdosis-Vitamin-C-Infusionstherapie - Vitamin C - Infusion - Vitamin-C-Mangel - Onkologie - Tumoren - Infekte
 

  • Die Literatur ist nur online verfügbar


    • Literaturliste zu: Vollbracht C, Suda R: Das Powervitamin. DHZ – Deutsche Heilpraktiker Zeitschrift, 2014; 5: 38–42
  • 1 Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA 1978; 75 (9) 4538-4542
    CrossrefGoogle Scholar
  • 2 Padayatty SJ et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med 2004; 140 (7) 533-537
    CrossrefGoogle Scholar
  • 3 Lunec J, Blake DR. The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis (RA). Free Radic Res Commun 1985; 1 (1) 31-39
    CrossrefGoogle Scholar
  • 4 Shanmugasundaram K, Kumar S, Rajajee S. Excessive free radical generation in the blood of children suffering from asthma. Clinica Chimica Acta 2001; 107-114
    Google Scholar
  • 5 Chen JY et al. Plasma vitamin C is lower in postherpetic neuralgia patients and administration of vitamin C reduces spontaneous pain but not brush-evoked pain. Clin J Pain 2009; 25 (7) 562-569
    CrossrefGoogle Scholar
  • 6 Jain SK et al. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J Hepatol 2002; 36 (6) 805-811
    CrossrefGoogle Scholar
  • 7 Unal M et al. Serum levels of antioxidant vitamins, copper, zinc and magnesium in children with chronic rhinosinusitis. J Trace Elem Med Biol 2004; 18 (2) 189-192
    CrossrefGoogle Scholar
  • 8 Mayland CR, Bennett MI, Allan K. Vitamin C deficiency in cancer patients. Palliat Med 2005; 19 (1) 17-20
    CrossrefPubMedGoogle Scholar
  • 9 PASCOE. PASCORBIN® 7,5 g im Praxisalltag: Über 1000 Ärzte und Heilpraktiker berichten über ihre Behandlungserfolge bei fast 200 000 Patienten. Ergebnisse einer retrospektiven Datenerhebung (2012). 2012
    Google Scholar
  • 10 Hume R, Weyers E. Changes in leucocyte ascorbic acid during the common cold. Scott Med J 1973; 18 (1) 3-7
    Google Scholar
  • 11 Panush RS, Delafuente JC. Vitamins and immunocompetence. World Rev Nutr Diet 1985; 45: 97-132
    Google Scholar
  • 12 Du WD et al. Therapeutic efficacy of highdose vitamin C on acute pancreatitis and its potential mechanisms. World J Gastroenterol 2003; 9 (11) 2565-2569
    Google Scholar
  • 13 Mikirova N et al. Effect of high-dose intravenous vitamin C on inflammation in cancer patients. J Transl Med 2012; 10: 0189
    CrossrefGoogle Scholar
  • 14 Mikirova N et al. Effect of high dose intravenous ascorbic acid on the level of inflammation in patients with rheumatoid arthritis. Modern Research in Inflammation 2012; 1 (2) 26-32
    CrossrefGoogle Scholar
  • 15 Hagel AF et al. Intravenous infusion of ascorbic acid decreases serum histamine concentrations in patients with allergic and non-allergic diseases. Naunyn Schmiedebergs Arch Pharmacol 2013;
    Google Scholar
  • 16 Vollbracht C et al. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany. In Vivo 2011; 25 (6) 983-990
    Google Scholar
  • 17 Yeom CH, Jung GC, Song KJ. Changes of Terminal Cancer Patients’ Health-related Quality of Life after High Dose Vitamin C Administration. J Korean Med Sci 2007; 22 (1) 7-11
    CrossrefGoogle Scholar
  • 18 Monti DA et al. Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One 2012; 7 (1) e29794
    CrossrefGoogle Scholar
  • 19 Welsh JL et al. Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemother Pharmacol 2013; 71 (3) 765-775
    CrossrefGoogle Scholar
  • 20 Ma Y et al. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med 2014; 6 (222) 222ra18
    CrossrefGoogle Scholar
  • 21 Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989; 86 (16) 6377-6381
    CrossrefGoogle Scholar
  • 22 Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988; 85 (24) 9748-9752
    CrossrefGoogle Scholar
  • 23 Chen Q et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA 2005;
    Google Scholar
  • 1 Fritz H et al. Intravenous Vitamin C and Cancer: A Systematic Review. Integr Cancer Ther 2014;
    Google Scholar